PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 52 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 163,538 | $1,782,564 | 0.12% |
| MMCAP International Inc. SPC | 375,000 | $22,913 | 0.01% |
| Atalaya Capital Management LP | 225,000 | $13,500 | 0.01% |
| Q Global Advisors, LLC | 170,785 | $10 | 0.01% |
| PERISCOPE CAPITAL INC. | 957,098 | $61,858 | 0.01% |
| CVI Holdings, LLC | 47,306 | $2,890 | 0.00% |
| Segantii Capital Management Ltd | 5,000 | $54,500 | 0.00% |
| Silver Rock Financial LP | 23,120 | $1,410 | 0.00% |
| Castle Creek Arbitrage, LLC | 200,000 | $12,220 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 714,827 | $43,604 | 0.00% |